DK1093469T3 - Lineære cyclodextrincopolymerer - Google Patents
Lineære cyclodextrincopolymererInfo
- Publication number
- DK1093469T3 DK1093469T3 DK99931889T DK99931889T DK1093469T3 DK 1093469 T3 DK1093469 T3 DK 1093469T3 DK 99931889 T DK99931889 T DK 99931889T DK 99931889 T DK99931889 T DK 99931889T DK 1093469 T3 DK1093469 T3 DK 1093469T3
- Authority
- DK
- Denmark
- Prior art keywords
- moieties
- linker
- cyclodextrin monomer
- cyclodextrin
- copolymer
- Prior art date
Links
- 229920000858 Cyclodextrin Polymers 0.000 title abstract 7
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 title abstract 7
- 125000005647 linker group Chemical group 0.000 abstract 5
- 239000000178 monomer Substances 0.000 abstract 5
- 229920000642 polymer Polymers 0.000 abstract 3
- 229920001577 copolymer Polymers 0.000 abstract 2
- 238000007334 copolymerization reaction Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/02—Polyamines
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/788—Of specified organic or carbon-based composition
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/906—Drug delivery
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Materials Engineering (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polyamides (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9155098P | 1998-07-01 | 1998-07-01 | |
US09/203,556 US6509323B1 (en) | 1998-07-01 | 1998-12-02 | Linear cyclodextrin copolymers |
PCT/US1999/014298 WO2000001734A1 (en) | 1998-07-01 | 1999-06-25 | Linear cyclodextrin copolymers |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1093469T3 true DK1093469T3 (da) | 2007-09-17 |
Family
ID=26784076
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK06024721.0T DK1764112T3 (da) | 1998-07-01 | 1999-06-25 | Fremgangsmåde til fremstilling af lineære cyclodextrin-copolymerer |
DK99931889T DK1093469T3 (da) | 1998-07-01 | 1999-06-25 | Lineære cyclodextrincopolymerer |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK06024721.0T DK1764112T3 (da) | 1998-07-01 | 1999-06-25 | Fremgangsmåde til fremstilling af lineære cyclodextrin-copolymerer |
Country Status (18)
Country | Link |
---|---|
US (1) | US6509323B1 (da) |
EP (2) | EP1764112B1 (da) |
JP (2) | JP4741729B2 (da) |
KR (1) | KR100851315B1 (da) |
CN (1) | CN100365024C (da) |
AT (1) | ATE361321T1 (da) |
AU (1) | AU763114C (da) |
BR (1) | BR9911754B1 (da) |
CA (1) | CA2336390C (da) |
CY (1) | CY1106797T1 (da) |
DE (1) | DE69935982T2 (da) |
DK (2) | DK1764112T3 (da) |
ES (2) | ES2403416T3 (da) |
HU (1) | HU229473B1 (da) |
IL (2) | IL140552A0 (da) |
MX (1) | MXPA01000206A (da) |
PT (1) | PT1093469E (da) |
WO (1) | WO2000001734A1 (da) |
Families Citing this family (126)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6509323B1 (en) * | 1998-07-01 | 2003-01-21 | California Institute Of Technology | Linear cyclodextrin copolymers |
KR100848121B1 (ko) * | 1998-07-01 | 2008-07-24 | 캘리포니아 인스티튜트 오브 테크놀로지 | 선형 사이클로덱스트린 공중합체 |
US7091192B1 (en) * | 1998-07-01 | 2006-08-15 | California Institute Of Technology | Linear cyclodextrin copolymers |
US7375096B1 (en) * | 1998-12-04 | 2008-05-20 | California Institute Of Technology | Method of preparing a supramolecular complex containing a therapeutic agent and a multi-dimensional polymer network |
JP2002531530A (ja) * | 1998-12-04 | 2002-09-24 | カリフォルニア インスティテュート オブ テクノロジー | 治療用薬剤を含む超分子錯体 |
US6740643B2 (en) * | 1999-01-21 | 2004-05-25 | Mirus Corporation | Compositions and methods for drug delivery using amphiphile binding molecules |
KR100371720B1 (ko) * | 2000-07-03 | 2003-02-06 | 광주과학기술원 | 사이클로덱스트린 또는 이의 유도체와 이작용성 또는다작용성 히드록시 화합물의 축중합물, 및 이의 제조방법 |
TWI321054B (en) * | 2000-12-19 | 2010-03-01 | California Inst Of Techn | Compositions containing inclusion complexes |
EP1275404A1 (en) * | 2001-07-11 | 2003-01-15 | SCA Hygiene Products AB | Odour regulation in hygiene products |
IL161733A0 (en) * | 2001-11-02 | 2005-11-20 | Insert Therapeutics Inc | Methods and compositions for therapeutic use of rna interference |
US20040063654A1 (en) * | 2001-11-02 | 2004-04-01 | Davis Mark E. | Methods and compositions for therapeutic use of RNA interference |
US7141540B2 (en) * | 2001-11-30 | 2006-11-28 | Genta Salus Llc | Cyclodextrin grafted biocompatible amphilphilic polymer and methods of preparation and use thereof |
TW515107B (en) * | 2001-12-25 | 2002-12-21 | Solidlite Corp | Power-saving light-emitting diode lamp |
CN1305932C (zh) * | 2002-02-22 | 2007-03-21 | 植入疗法公司 | 碳水化合物修饰的聚合物、其组合物及其应用 |
US20050260259A1 (en) * | 2004-04-23 | 2005-11-24 | Bolotin Elijah M | Compositions for treatment with glucagon-like peptide, and methods of making and using the same |
US7635463B2 (en) * | 2002-02-27 | 2009-12-22 | Pharmain Corporation | Compositions for delivery of therapeutics and other materials |
US7138105B2 (en) * | 2002-02-27 | 2006-11-21 | Pharmain | Compositions for delivery of therapeutics and other materials, and methods of making and using the same |
FR2842106B1 (fr) * | 2002-07-11 | 2006-07-14 | Centre Nat Rech Scient | Dispersions aqueuses de particules nanometriques ou micrometriques pour l'encapsulation de composes chimiques |
ATE533513T1 (de) * | 2002-09-06 | 2011-12-15 | Cerulean Pharma Inc | Polymere auf basis von cyclodextrin zur verabreichung von an diese kovalent gebundene arzneimittel |
CA2892003A1 (en) * | 2002-09-06 | 2004-03-18 | Cerulean Pharma Inc. | Modified cyclodextrin ring compounds having exactly two hydroxyl moieties substituted with an amino acid for therapeutics delivery |
WO2004032862A2 (en) * | 2002-10-09 | 2004-04-22 | Insert Therapeutics, Inc. | Cyclodextrin-based materials, compositions and uses related thereto |
US7879351B2 (en) * | 2002-10-29 | 2011-02-01 | Transave, Inc. | High delivery rates for lipid based drug formulations, and methods of treatment thereof |
US7718189B2 (en) | 2002-10-29 | 2010-05-18 | Transave, Inc. | Sustained release of antiinfectives |
ES2831305T3 (es) * | 2002-10-29 | 2021-06-08 | Insmed Inc | Liposomas que comprenden un aminoglucósido para el tratamiento de infecciones pulmonares |
SG129240A1 (en) * | 2003-01-23 | 2007-02-26 | Agency Science Tech & Res | Biodegradable copolymer and nucleic acid delivery system |
EP2216407B1 (en) | 2003-03-07 | 2016-01-13 | Alnylam Pharmaceuticals, Inc. | Therapeutic compositions |
US20070179100A1 (en) * | 2003-04-09 | 2007-08-02 | Muthiah Manoharan | Protected monomers |
US7723509B2 (en) * | 2003-04-17 | 2010-05-25 | Alnylam Pharmaceuticals | IRNA agents with biocleavable tethers |
EP1620544B1 (en) | 2003-04-17 | 2018-09-19 | Alnylam Pharmaceuticals Inc. | MODIFIED iRNA AGENTS |
US8796436B2 (en) | 2003-04-17 | 2014-08-05 | Alnylam Pharmaceuticals, Inc. | Modified iRNA agents |
US8017762B2 (en) * | 2003-04-17 | 2011-09-13 | Alnylam Pharmaceuticals, Inc. | Modified iRNA agents |
AU2004232964B2 (en) | 2003-04-17 | 2011-09-22 | Alnylam Pharmaceuticals, Inc. | Protected monomers |
US7851615B2 (en) * | 2003-04-17 | 2010-12-14 | Alnylam Pharmaceuticals, Inc. | Lipophilic conjugated iRNA agents |
CA2542232A1 (en) | 2003-06-09 | 2005-01-20 | Alnylam Pharmaceuticals, Inc. | Method for treating neurodegenerative disease by inhibiting alpha-synuclein |
US8034619B2 (en) | 2003-12-19 | 2011-10-11 | University Of Cincinnati | Polyamides for nucleic acid delivery |
US20070020299A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
RU2006127432A (ru) | 2003-12-31 | 2008-02-10 | Сайдекс, Инк. (Us) | Ингаляционная композиция, содержащая сульфоалкиловый эфир циклодекстрина и кортикостероид, полученная из единичной дозы суспензии |
US20070020196A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid prepared from a unit dose suspension |
US20070020298A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid |
ATE508190T1 (de) | 2004-03-05 | 2011-05-15 | Benitec Inc | Mehrfachpromotor-expressionskassetten zurgleichzeitigen zuführung von rnai-agentien |
WO2005088655A1 (en) * | 2004-03-12 | 2005-09-22 | The Provost Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin | A magnetoresistive medium |
JP4339912B2 (ja) * | 2004-09-18 | 2009-10-07 | ミレ グリーン コンストラクション カンパニー リミテッド | 遮集管渠の土砂流入防止装置 |
SG158174A1 (en) * | 2005-01-06 | 2010-01-29 | Benitec Inc | Rnai agents for maintenance of stem cells |
US7803611B2 (en) | 2005-02-03 | 2010-09-28 | Benitec, Inc. | RNAi expression constructs |
US8008468B2 (en) * | 2005-02-16 | 2011-08-30 | Benitec, Inc. | RNAi expression constructs with liver-specific enhancer/promoter |
JP2008537551A (ja) | 2005-03-31 | 2008-09-18 | カランド ファーマシューティカルズ, インコーポレイテッド | リボヌクレオチドレダクターゼサブユニット2の阻害剤およびその使用 |
CN101228176A (zh) * | 2005-04-28 | 2008-07-23 | 贝尼泰克有限公司 | 用于同时递送与杂合表达模式相关的RNAi因子的多重RNAi表达盒 |
CA2628300C (en) | 2005-11-02 | 2018-04-17 | Protiva Biotherapeutics, Inc. | Modified sirna molecules and uses thereof |
EP3718532A1 (en) | 2005-12-08 | 2020-10-07 | Insmed Incorporated | Lipid-based compositions of antiinfectives for treating pulmonary infections |
KR20150125732A (ko) | 2005-12-19 | 2015-11-09 | 파마인 코포레이션 | 치료제를 전달하기 위한 소수성 코어 담체 조성물, 이 조성물의 제조 방법 및 그 조성물의 이용 방법 |
AU2006327551A1 (en) * | 2005-12-19 | 2007-06-28 | Capsutech Ltd. | Cyclodextrin-containing polymers and uses thereof |
US20070160542A1 (en) * | 2005-12-20 | 2007-07-12 | Verus Pharmaceuticals, Inc. | Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile |
US20070178049A1 (en) * | 2005-12-20 | 2007-08-02 | Verus Pharmaceuticals, Inc. | Systems and methods for the delivery of corticosteroids having an enhanced pharmacokinetic profile |
US20070185066A1 (en) * | 2005-12-20 | 2007-08-09 | Verus Pharmaceuticals, Inc. | Systems and methods for the delivery of corticosteroids |
US20070197486A1 (en) * | 2005-12-20 | 2007-08-23 | Verus Pharmaceuticals, Inc. | Methods and systems for the delivery of corticosteroids |
US20070249572A1 (en) * | 2005-12-20 | 2007-10-25 | Verus Pharmaceuticals, Inc. | Systems and methods for the delivery of corticosteroids |
JP2009526860A (ja) * | 2006-02-15 | 2009-07-23 | ティカ レーケメデル アーベー | 安定したコルチコステロイド混合物 |
US8501478B2 (en) | 2006-06-15 | 2013-08-06 | University Of Cincinnati | Trehalose click polymers for delivery of biologically active molecules |
US20080176958A1 (en) * | 2007-01-24 | 2008-07-24 | Insert Therapeutics, Inc. | Cyclodextrin-based polymers for therapeutics delivery |
US20100196455A1 (en) * | 2007-05-04 | 2010-08-05 | Transave, Inc. | Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof |
US9333214B2 (en) | 2007-05-07 | 2016-05-10 | Insmed Incorporated | Method for treating pulmonary disorders with liposomal amikacin formulations |
US9114081B2 (en) | 2007-05-07 | 2015-08-25 | Insmed Incorporated | Methods of treating pulmonary disorders with liposomal amikacin formulations |
US9119783B2 (en) | 2007-05-07 | 2015-09-01 | Insmed Incorporated | Method of treating pulmonary disorders with liposomal amikacin formulations |
US7960336B2 (en) * | 2007-08-03 | 2011-06-14 | Pharmain Corporation | Composition for long-acting peptide analogs |
US8563527B2 (en) * | 2007-08-20 | 2013-10-22 | Pharmain Corporation | Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the same |
AU2008298592A1 (en) * | 2007-09-14 | 2009-03-19 | Nitto Denko Corporation | Drug carriers |
CN101809039B (zh) * | 2007-09-28 | 2012-08-29 | 那诺蒂克株式会社 | 叶酸修饰的环糊精化合物、其制备方法、靶向性药物传递系统用的药物传递剂、药物组合物及造影剂 |
US8054177B2 (en) * | 2007-12-04 | 2011-11-08 | Avaya Inc. | Systems and methods for facilitating a first response mission at an incident scene using patient monitoring |
WO2009082817A1 (en) | 2007-12-27 | 2009-07-09 | Protiva Biotherapeutics, Inc. | Silencing of polo-like kinase expression using interfering rna |
US20090176892A1 (en) * | 2008-01-09 | 2009-07-09 | Pharmain Corporation | Soluble Hydrophobic Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same |
EP2283133A2 (en) | 2008-04-04 | 2011-02-16 | Calando Pharmaceuticals, Inc. | Compositions and use of epas1 inhibitors |
EP2281041B1 (en) | 2008-04-15 | 2014-07-02 | Protiva Biotherapeutics Inc. | Silencing of csn5 gene expression using interfering rna |
US20110223665A1 (en) * | 2008-07-25 | 2011-09-15 | Alnylam Pharmaceuticals, Inc. | ENHANCEMENT OF siRNA SILENCING ACTIVITY USING UNIVERSAL BASES OR MISMATCHES IN THE SENSE STRAND |
US8309530B2 (en) * | 2009-02-04 | 2012-11-13 | Washington State University | Compositions and methods for modulating ghrelin-mediated conditions |
WO2010099466A2 (en) | 2009-02-26 | 2010-09-02 | The Regents Of The University Of California | A supramolecular approach for preparation of size controllable nanoparticles |
EP2503888A4 (en) | 2009-11-23 | 2015-07-29 | Cerulean Pharma Inc | POLYMERS ON CYCLODEXTRINBASIS FOR THERAPEUTIC ADMINISTRATION |
WO2011090940A1 (en) | 2010-01-19 | 2011-07-28 | Cerulean Pharma Inc. | Cyclodextrin-based polymers for therapeutic delivery |
EP2571525A4 (en) | 2010-05-18 | 2016-04-27 | Cerulean Pharma Inc | Compositions and methods for treating autoimmune and other diseases |
JP2013530187A (ja) | 2010-06-17 | 2013-07-25 | ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンティッド バイ ザ シークレタリー デパートメント オブ ヘルス アンド ヒューマン サービシーズ | 炎症性疾患を治療するための組成物及び方法。 |
SG196779A1 (en) | 2010-07-08 | 2014-02-13 | Bonac Corp | Single-strand nucleic acid molecule for controlling gene expression |
KR101849801B1 (ko) | 2010-08-03 | 2018-04-17 | 가부시키가이샤 보낙 | 함질소 지환식 골격을 갖는 일본쇄 핵산 분자 |
US20130210663A1 (en) | 2010-08-04 | 2013-08-15 | Cizzle Biotechnology Limited | Methods and compounds for the diagnosis and treatment of cancer |
US10307372B2 (en) | 2010-09-10 | 2019-06-04 | The Johns Hopkins University | Rapid diffusion of large polymeric nanoparticles in the mammalian brain |
WO2012061413A2 (en) | 2010-11-01 | 2012-05-10 | Marshall Edwards, Inc. | Isoflavonoid compositions and methods for the treatment of cancer |
US20120302505A1 (en) * | 2011-04-21 | 2012-11-29 | Fetzer Oliver S | Cyclodextrin-based polymers for therapeutic delivery |
US20150240238A1 (en) | 2011-11-17 | 2015-08-27 | The Regents Of The University Of California | Therapeutic rna switches compositions and methods of use |
US20140329913A1 (en) | 2011-12-14 | 2014-11-06 | The Johns Hopkins University | Nanoparticles with enhanced mucosal penetration or decreased inflammation |
US9035039B2 (en) | 2011-12-22 | 2015-05-19 | Protiva Biotherapeutics, Inc. | Compositions and methods for silencing SMAD4 |
WO2013103146A1 (ja) | 2012-01-07 | 2013-07-11 | 株式会社ボナック | アミノ酸骨格を有する一本鎖核酸分子 |
CN104936620B (zh) | 2012-01-19 | 2019-08-09 | 约翰霍普金斯大学 | 增强粘膜渗透的纳米粒子调配物 |
WO2013116200A1 (en) * | 2012-01-31 | 2013-08-08 | Cerulean Pharma Inc. | Cyclodextrin-based polymers for therapeutic delivery |
EP2838653A4 (en) | 2012-04-18 | 2015-11-25 | Cerulean Pharma Inc | METHODS AND SYSTEMS FOR POLYMER PRECIPITATION AND PARTICLE GENERATION |
EP2852391B1 (en) | 2012-05-21 | 2021-11-17 | Insmed Incorporated | Systems for treating pulmonary infections |
US20140094432A1 (en) | 2012-10-02 | 2014-04-03 | Cerulean Pharma Inc. | Methods and systems for polymer precipitation and generation of particles |
RU2018135921A (ru) | 2012-11-29 | 2019-02-05 | Инсмед Инкорпорейтед | Стабилизированные составы ванкомицина |
US10568975B2 (en) | 2013-02-05 | 2020-02-25 | The Johns Hopkins University | Nanoparticles for magnetic resonance imaging tracking and methods of making and using thereof |
WO2015127368A1 (en) | 2014-02-23 | 2015-08-27 | The Johns Hopkins University | Hypotonic microbicidal formulations and methods of use |
US10335500B2 (en) | 2014-05-12 | 2019-07-02 | The Johns Hopkins University | Highly stable biodegradable gene vector platforms for overcoming biological barriers |
CA2948844C (en) | 2014-05-12 | 2020-06-30 | The Johns Hopkins University | Engineering synthetic brain penetrating gene vectors |
ES2755941T3 (es) | 2014-05-15 | 2020-04-24 | Insmed Inc | Métodos para tratar infecciones pulmonares micobacterianas no tuberculosas |
EP3201338B1 (en) | 2014-10-02 | 2021-11-03 | Arbutus Biopharma Corporation | Compositions and methods for silencing hepatitis b virus gene expression |
WO2016123125A1 (en) | 2015-01-27 | 2016-08-04 | The Johns Hopkins University | Hypotonic hydrogel formulations for enhanced transport of active agents at mucosal surfaces |
ES2877712T3 (es) | 2015-02-02 | 2021-11-17 | Mei Pharma Inc | Terapias combinadas para su uso en el tratamiento del cáncer de mama |
WO2016197132A1 (en) | 2015-06-04 | 2016-12-08 | Protiva Biotherapeutics Inc. | Treating hepatitis b virus infection using crispr |
EP3329003A2 (en) | 2015-07-29 | 2018-06-06 | Arbutus Biopharma Corporation | Compositions and methods for silencing hepatitis b virus gene expression |
EP3405501B1 (en) * | 2016-01-21 | 2023-11-15 | Aten Porus Lifesciences | Cyclodextrin based polymers, methods, compositions and applications thereof |
WO2017143042A2 (en) | 2016-02-16 | 2017-08-24 | Yale University | Compositions for enhancing targeted gene editing and methods of use thereof |
WO2018102769A1 (en) * | 2016-12-01 | 2018-06-07 | Bluelink Pharmaceuticals, Inc. | Treatment of cancer |
US20230192931A1 (en) * | 2017-03-02 | 2023-06-22 | Osaka University | Host-group-containing polymerizable monomer, polymer material, method for producing same, and clathrate compound and method for producing same |
WO2018169960A1 (en) | 2017-03-17 | 2018-09-20 | The Johns Hopkins University | Nanoparticle formulations for enhanced drug delivery to the bladder |
WO2018187493A1 (en) | 2017-04-04 | 2018-10-11 | Yale University | Compositions and methods for in utero delivery |
US20210188895A1 (en) | 2017-10-13 | 2021-06-24 | Bonac Corporation | Single-stranded nucleic acid molecule, and production method therefor |
US10765638B2 (en) | 2017-11-03 | 2020-09-08 | Yale University | Particle formulation with polycation complex |
WO2019191627A1 (en) | 2018-03-30 | 2019-10-03 | Insmed Incorporated | Methods for continuous manufacture of liposomal drug products |
WO2020033951A1 (en) | 2018-08-10 | 2020-02-13 | Yale University | Compositions and methods for embryonic gene editing in vitro |
CN110016194A (zh) * | 2019-04-16 | 2019-07-16 | 无锡纯宇环保制品有限公司 | 一种有利于水体净化的可降解塑料袋 |
US20220372474A1 (en) | 2019-06-21 | 2022-11-24 | Yale University | Hydroxymethyl-modified gamma-pna compositions and methods of use thereof |
US20220243211A1 (en) | 2019-06-21 | 2022-08-04 | Yale University | Peptide nucleic acid compositions with modified hoogsteen binding segments and methods of use thereof |
WO2021022161A1 (en) | 2019-07-31 | 2021-02-04 | Yale University | Compositions and methods for treating sickle cell disease |
WO2021081043A1 (en) | 2019-10-22 | 2021-04-29 | The Johns Hopkins University | Mucus penetrating particle compositions and methods of use thereof enhancing immune response |
US20230285576A1 (en) | 2020-08-05 | 2023-09-14 | Ellipses Pharma Ltd | Treatment of cancer using a cyclodextrin-containing polymer-topoisomerase inhibitor conjugate and a parp inhibitor |
EP4228670A1 (en) | 2020-10-15 | 2023-08-23 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Tg2 inhibitors for improving mucociliary clearance in respiratory diseases |
CN115160454A (zh) * | 2021-04-01 | 2022-10-11 | 四川大学 | 一种基于聚-β-环糊精与金刚烷主客体作用的超分子多醛化合物及其制备方法 |
WO2022261115A1 (en) | 2021-06-07 | 2022-12-15 | Yale University | Peptide nucleic acids for spatiotemporal control of crispr-cas binding |
WO2023064732A1 (en) | 2021-10-15 | 2023-04-20 | Georgia State University Research Foundation, Inc. | Delivery of therapeutic recombinant uricase using nanoparticles |
WO2023223787A1 (ja) * | 2022-05-17 | 2023-11-23 | リンテック株式会社 | 粘着性組成物、粘着剤、粘着シート、表示体および繰り返し屈曲デバイス |
Family Cites Families (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE32268E (en) * | 1973-03-01 | 1986-10-21 | Strategic Medical Research Corp. | Therapeutic composition and method of therapeutically treating warm blooded animals therewith |
JPS58167613A (ja) * | 1982-03-26 | 1983-10-03 | Mitsubishi Petrochem Co Ltd | 水溶性シクロデキストリン含有重合体の製造法 |
HU191101B (en) * | 1983-02-14 | 1987-01-28 | Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu | Process for preparing water-soluble cyclodextrin polymers substituted with ionic groups |
US4727064A (en) | 1984-04-25 | 1988-02-23 | The United States Of America As Represented By The Department Of Health And Human Services | Pharmaceutical preparations containing cyclodextrin derivatives |
US5166320A (en) | 1987-04-22 | 1992-11-24 | University Of Connecticut | Carrier system and method for the introduction of genes into mammalian cells |
EP0362290A4 (en) * | 1987-06-17 | 1991-09-25 | Princess Margaret Children's Medical Research Foundation (Inc.) | Cloning of mite allergens |
US4774329A (en) | 1987-08-04 | 1988-09-27 | American Maize-Products Company | Controlled release agent for cetylpyridinium chloride |
US4941996A (en) | 1987-10-19 | 1990-07-17 | Minnesota Mining And Manufacturing Company | Inclusion complexes providing second harmonic generation |
HU203899B (en) * | 1988-05-03 | 1991-10-28 | Forte Fotokemiai Ipar | Process for producing gelatine-cyclodextreine polymeres |
US4902788A (en) | 1988-09-29 | 1990-02-20 | Uop | Crosslinked cyclodextrins supported on porous refractory inorganic oxides |
JPH03221505A (ja) | 1990-01-29 | 1991-09-30 | Toppan Printing Co Ltd | シクロデキストリンポリマーの合成方法及びシクロデキストリン膜の製造方法 |
IT1241417B (it) | 1990-03-06 | 1994-01-14 | Vectorpharma Int | Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione |
DE4009825A1 (de) | 1990-03-27 | 1991-10-02 | Consortium Elektrochem Ind | Wasserunloesliche cyclodextrin-polymerisate und verfahren zu deren herstellung |
JPH0425505A (ja) * | 1990-05-21 | 1992-01-29 | Toppan Printing Co Ltd | シクロデキストリンポリマー及びシクロデキストリン膜の製造方法 |
FR2665169A1 (fr) | 1990-07-30 | 1992-01-31 | Rhone Poulenc Chimie | Composes d'inclusion de cyclodextrines enfermant des antioxydants phenoliques et leur utilisation dans les polymeres. |
JPH04106101A (ja) * | 1990-08-27 | 1992-04-08 | Showa Denko Kk | シクロデキストリンポリマーおよびその製造方法 |
WO1992006127A1 (fr) | 1990-10-01 | 1992-04-16 | Toppan Printing Co., Ltd. | Polymere de cyclodextrine et film de cyclodextrine forme a partir de celui-ci |
JPH0586103A (ja) * | 1990-10-01 | 1993-04-06 | Toppan Printing Co Ltd | シクロデキストリンポリマー |
WO1992009637A1 (fr) * | 1990-11-30 | 1992-06-11 | Toppan Printing Co., Ltd. | Procede de production d'un derive de cyclodextrine et polymere contenant de la cyclodextrine immobilisee |
CA2116431A1 (en) | 1991-09-06 | 1993-03-18 | Gurcharn S. Sidhu | Composition and method for reducing cholesterol concentration |
NZ244306A (en) | 1991-09-30 | 1995-07-26 | Boehringer Ingelheim Int | Composition for introducing nucleic acid complexes into eucaryotic cells, complex containing nucleic acid and endosomolytic agent, peptide with endosomolytic domain and nucleic acid binding domain and preparation |
JP3221505B2 (ja) | 1992-02-06 | 2001-10-22 | 日本信号株式会社 | 移動体の運行管理装置 |
IT1256134B (it) | 1992-09-09 | 1995-11-29 | Luigi Boltri | Sali lipofili contenenti isotopi neutron attivabili e composizioni che li contengono |
CA2129108A1 (en) | 1992-11-30 | 1994-06-09 | Dirk Vetter | Polymerisable carbohydrate esters, polymers therefrom and their use |
TW328535B (en) | 1993-07-02 | 1998-03-21 | Novartis Ag | Functional photoinitiators and their manufacture |
TW307775B (en) | 1994-02-15 | 1997-06-11 | Novartis Erfind Verwalt Gmbh | Unsaturated carbohydrate derivatives, polymers thereof and their use |
US5691316A (en) | 1994-06-01 | 1997-11-25 | Hybridon, Inc. | Cyclodextrin cellular delivery system for oligonucleotides |
US5776842A (en) | 1994-06-23 | 1998-07-07 | Cellresin Technologies, Llc | Cellulosic web with a contaminant barrier or trap |
JP3699141B2 (ja) | 1994-09-24 | 2005-09-28 | 伸彦 由井 | 超分子構造の生体内分解性医薬高分子集合体及びその調製方法 |
JP3830198B2 (ja) | 1996-03-29 | 2006-10-04 | 東光薬品工業株式会社 | 超分子構造高分子集合体を用いた皮膚透過性インドメタシン外用剤 |
US6048736A (en) | 1998-04-29 | 2000-04-11 | Kosak; Kenneth M. | Cyclodextrin polymers for carrying and releasing drugs |
US6509323B1 (en) * | 1998-07-01 | 2003-01-21 | California Institute Of Technology | Linear cyclodextrin copolymers |
KR100848121B1 (ko) * | 1998-07-01 | 2008-07-24 | 캘리포니아 인스티튜트 오브 테크놀로지 | 선형 사이클로덱스트린 공중합체 |
JP2002531530A (ja) * | 1998-12-04 | 2002-09-24 | カリフォルニア インスティテュート オブ テクノロジー | 治療用薬剤を含む超分子錯体 |
US6740643B2 (en) | 1999-01-21 | 2004-05-25 | Mirus Corporation | Compositions and methods for drug delivery using amphiphile binding molecules |
WO2000075164A1 (en) | 1999-06-07 | 2000-12-14 | Mirus Corporation | COMPOSITIONS AND METHODS FOR DRUG DELIVERY USING pH SENSITIVE MOLECULES |
WO2000075162A1 (en) | 1999-06-07 | 2000-12-14 | Mirus Corporation | A compound containing a labile disulfide bond |
EP1233671A4 (en) | 1999-11-29 | 2005-11-02 | Mirus Corp | COMPOSITIONS AND METHODS OF DISPOSING MEDICAMENTS USING AMPHIPHILIC BINDING MOLECULARS |
-
1998
- 1998-12-02 US US09/203,556 patent/US6509323B1/en not_active Expired - Lifetime
-
1999
- 1999-06-25 KR KR1020017000019A patent/KR100851315B1/ko not_active IP Right Cessation
- 1999-06-25 AT AT99931889T patent/ATE361321T1/de active
- 1999-06-25 DK DK06024721.0T patent/DK1764112T3/da active
- 1999-06-25 ES ES06024721T patent/ES2403416T3/es not_active Expired - Lifetime
- 1999-06-25 PT PT99931889T patent/PT1093469E/pt unknown
- 1999-06-25 IL IL14055299A patent/IL140552A0/xx active IP Right Grant
- 1999-06-25 EP EP06024721A patent/EP1764112B1/en not_active Expired - Lifetime
- 1999-06-25 MX MXPA01000206A patent/MXPA01000206A/es unknown
- 1999-06-25 JP JP2000558134A patent/JP4741729B2/ja not_active Expired - Lifetime
- 1999-06-25 AU AU48305/99A patent/AU763114C/en not_active Expired
- 1999-06-25 ES ES99931889T patent/ES2285844T3/es not_active Expired - Lifetime
- 1999-06-25 CN CNB998083801A patent/CN100365024C/zh not_active Expired - Fee Related
- 1999-06-25 WO PCT/US1999/014298 patent/WO2000001734A1/en active IP Right Grant
- 1999-06-25 DK DK99931889T patent/DK1093469T3/da active
- 1999-06-25 DE DE69935982T patent/DE69935982T2/de not_active Expired - Lifetime
- 1999-06-25 HU HU0105472A patent/HU229473B1/hu unknown
- 1999-06-25 CA CA2336390A patent/CA2336390C/en not_active Expired - Lifetime
- 1999-06-25 BR BRPI9911754-1A patent/BR9911754B1/pt not_active IP Right Cessation
- 1999-06-25 EP EP99931889A patent/EP1093469B1/en not_active Expired - Lifetime
-
2000
- 2000-12-26 IL IL140552A patent/IL140552A/en not_active IP Right Cessation
-
2007
- 2007-06-25 CY CY20071100840T patent/CY1106797T1/el unknown
-
2010
- 2010-09-01 JP JP2010195783A patent/JP2011006695A/ja not_active Withdrawn
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1093469T3 (da) | Lineære cyclodextrincopolymerer | |
BR0115834A (pt) | Polìmeros em forma de pente modificados cationicamente, na base de ácido acriloildimetiltaurìnico | |
BR0115839A (pt) | Polìmeros em forma de pente enxertados, na base de ácido acriloildimetiltaurìnico | |
ATE335025T1 (de) | Pfropfpolymerisate mit stickstoffheterocyclen enthaltenden seitenketten | |
DE60114599D1 (de) | Adehyde enthaltende polymere als nassfestmittel | |
BR0214120A (pt) | Polìmeros de enxerto, processo para a preparação e uso dos mesmos | |
BR0215142A (pt) | Composição polimérica termoplástica, artigos obtidos por modelagem e uso do polìmero | |
BR0115763A (pt) | Polìmeros em forma de pente modificados por flúor à base de ácido acriloildimetiltaurìnico | |
BR0115813A (pt) | Polìmeros em forma de pente modificados por silìcio à base de ácido acriloil dimetiltaurìnico | |
DE69709110D1 (de) | Polymerisation mit "living" kennzeichen | |
TW200631604A (en) | Ophthalmic compositions comprising polyether substituted polymers | |
ES2118718T3 (es) | Copolimeros olefinas y su produccion. | |
FI894278A0 (fi) | Menetelmä diallyylidimetyyliammoniumkloridin ja akryyliamidin korkean molekyylipainon omaavien kopolymeerien valmistamiseksi liuoksessa | |
BRPI0516921A (pt) | homopolìmero ou copolìmero de etileno e processo de polimerização com iniciação via radicais livres | |
NO893630D0 (no) | Fremgangsmaate for fremstilling av en vannloeselig kopolymer | |
BR8707604A (pt) | Copolimeros de etileno | |
ES2045352T3 (es) | Destintado de papeles usados. | |
DE60112290D1 (de) | Polymerisationsinitiator und seine verwendung | |
BR0015948A (pt) | Polìmero de propileno, uso do mesmo, fibra, filme ou peça moldada, e, uso de uma peça moldada | |
AU5853499A (en) | Cationic polymers and their use | |
WO1997049718A3 (fr) | Conjugues d'un oligonucleotide/polymere conducteur electronique avec une molecule d'interet, et leurs utilisations | |
ATE278719T1 (de) | Teilverzweigte polymere | |
WO2021222523A3 (en) | Drug loaded peptide brush polymers | |
BR9906687A (pt) | Aperfeiçoamento da estabilidade oxidativa térmica de polìmeros acrìlicos | |
FI904926A0 (fi) | Silloituskykyinen eteenikopolymeeri, sen valmistus ja silloitus |